Arthrotec: the evidence speaks for itself.


Journal Article (Review)

This article examines the most recently published scientific literature on arthritis therapy options and available mucosal-protective agents. Emphasis is placed on the risks of current nonsteroidal anti-inflammatory drug (NSAID) therapy, the options for reducing such risks, and the published information that either supports or refutes current thinking in these areas. A comprehensive evaluation is made of clinical data related to the use of Arthrotec (diclofenac/misoprostol) in the treatment of arthritis. A recent meta-analysis of the prophylaxis of NSAID-associated upper gastrointestinal complications is reviewed. The results of this meta-analysis should help to consolidate much of the current scientific literature on the safe and effective treatment of arthritis.

Full Text

Duke Authors

Cited Authors

  • Morgan, D

Published Date

  • January 1999

Published In

Volume / Issue

  • 109 /

Start / End Page

  • 13 - 18

PubMed ID

  • 10422542

Pubmed Central ID

  • 10422542

Electronic International Standard Serial Number (EISSN)

  • 1502-7740

International Standard Serial Number (ISSN)

  • 0301-3847

Digital Object Identifier (DOI)

  • 10.1080/030097499750042380


  • eng